Development of a Catalyst Based on Titanium Nanoparticles in a Zeolite Matrix

Author(s):  
V. A. Demchuk ◽  
B. B. Kalinichenko ◽  
E. V. Bogomazova ◽  
V. I. Rozhdestvina
2012 ◽  
Vol 18 (2) ◽  
pp. 276
Author(s):  
Weiwei YANG ◽  
Liang ZHANG ◽  
Guoqiang ZHAN ◽  
Yong TAO ◽  
Xiaohong HE ◽  
...  

2021 ◽  
Vol 22 (3) ◽  
pp. 1067
Author(s):  
Georgios Romanos ◽  
Gerard Fischer ◽  
Rafael Delgado-Ruiz

The objective of this review was to analyze the process of wear of implants leading to the shedding of titanium particles into the peri-implant hard and soft tissues. Titanium is considered highly biocompatible with low corrosion and toxicity, but recent studies indicate that this understanding may be misleading as the properties of the material change drastically when titanium nanoparticles (NPs) are shed from implant surfaces. These NPs are immunogenic and are associated with a macrophage-mediated inflammatory response by the host. The literature discussed in this review indicates that titanium NPs may be shed from implant surfaces at the time of implant placement, under loading conditions, and during implant maintenance procedures. We also discuss the significance of the micro-gap at the implant-abutment interface and the effect of size of the titanium particles on their toxicology. These findings are significant as the titanium particles can have adverse effects on local soft and hard tissues surrounding implants, implant health and prognosis, and even the health of systemic tissues and organs.


2021 ◽  
Vol 23 (1) ◽  
Author(s):  
Yurii A. Kurapov ◽  
Stanislav Е. Litvin ◽  
Nadezhda N. Belyavina ◽  
Elena I. Oranskaya ◽  
Sergei M. Romanenko ◽  
...  

2021 ◽  
pp. 131189
Author(s):  
Eshraga A.A. Siddig ◽  
Yu Zhang ◽  
Baojing Yang ◽  
Tianshu Wang ◽  
Jianjun Shi ◽  
...  

Author(s):  
HAYDER H. ABED ◽  
ESTABRAQ AR. ALWASITI ◽  
AMIR T. TAWFEEQ

Objective: Blood clots are the main cause of death worldwide by stroke and myocardial infarction. Streptokinase a thrombolytic agent that is used in the treatment of circulatory disorders. Methods: Titanium Nanoparticles was supplied from Changsha Santech Co. Its characterized were studied using (FT-IR, XRD, AFM, FE-SEM). Streptokinase at concentration 0.1 mg/ml was conjugated with Titanium nanoparticles using PH equal to 5.2 with continuous stirring. Formation of Streptokinase loading Titanium nanoparticles confirmed using FT-IR, Ninhydrine’s test and Bradford protein assay. Physicochemical Properties were studied in vitro. Thrombolytic activity in vitro was determined using d–dimer indicator and weight of blood clot after treatment as indicators of thrombolytic activity. Results: Titanium nanoparticles show particle size at range 31 nm. The thrombolytic activity of streptokinase loading Titanium nanoparticles shows significant value in d-dimer and weight of blood clot compared with the control group and non-significant compared with an equivalent amount of streptokinase alone. Conclusion: Titanium nanoparticles conjugated with streptokinase show high thrombolytic activity against blood clots in vitro.


2018 ◽  
Vol 47 ◽  
pp. 63-69 ◽  
Author(s):  
Lilian Cristina Pereira ◽  
Murilo Pazin ◽  
Mariana Furio Franco-Bernardes ◽  
Airton da Cunha Martins ◽  
Gustavo Rafael Mazzaron Barcelos ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document